The First Antibiotic-Eluting BioEnvelope
Designed to Protect Patients with Cardiac Implantable Electronic Devices (CIEDs)
Featuring powerful antibiotic therapy and advanced tissue engineering, EluPro BioEnvelopes are specifically designed to prevent post-operative complications and support regeneration of healthy, vascularized tissue
Finally, an antibiotic envelope you’ll actually love to use.
EluPro: Advanced Tissue Engineering for Optimal Protection
Embedded with rifampin and minocycline, the EluPro BioEnvelope is engineered for the extended delivery of the antibiotics at the surgical site. EluPro is constructed of a unique extracellular matrix that supports the regeneration of healthy, vascularized tissue1 versus fibrotic, calcified tissue.
- Proven antibiotics2— rifampin and minocycline— to prevent bacterial colonization
- Specifically-engineered extracellular matrix to regenerate into healthy vascularized tissue1
- Soft feel and natural lubricity when hydrated, EluPro conforms to the shape of the CIED and provides both acute and long-term device stability
“When I implant a pacemaker or defibrillator, minimizing the risk of any future complications is crucial. However, the body’s natural immunity can treat the device as a foreign object. [EluPro] combines the remodeling properties of regenerative medicine through extracellular matrix along with the long-acting antibiotic delivery to create a healthy environment for every device implantation.”
Benjamin D’Souza, MD, FACC, FHRS
Better Feel.
Better Function.
For A Better Future.
- Catanzaro JN, et al. Circulation. 2022; 146: A11052; Catanzaro JN, et al. Heart Rhythm. 2023;20(5): S712-S713
- Data on file
WMK-1819-01A